PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), characterized by lack of estrogen receptor (ER) and progesterone receptor (PR) and absence of human epidermal growth factor receptor type 2 (HER2) over-expression, accounts for 10-20% of invasive breast cancers (1, 2).